P14-15 LB. The safety and immunogenicity of HIV-1 vaccines based on DNA and replication competent vaccinia vector in phase I clinical trial

Y. Shao; T. Li; H. Wolf; Y. Liu; Y. Liu; H. Wang; H. Zhu; W. Lv; W. Lin; J. Chen; H. Liang; K. Hong; M. Jia

ArticleOPEN ACCESS

P14-15 LB. The safety and immunogenicity of HIV-1 vaccines based on DNA and replication competent vaccinia vector in phase I clinical trial

Shao Y
Li T
Wolf H
et al.

Retrovirology

DOI: 10.1186/1742-4690-6-S3-P404

8Citations

4Readers

Cite

CITATION STYLE

APA

Shao, Y., Li, T., Wolf, H., Liu, Y., Liu, Y., Wang, H., … Jia, M. (2009, October 22). P14-15 LB. The safety and immunogenicity of HIV-1 vaccines based on DNA and replication competent vaccinia vector in phase I clinical trial. Retrovirology. https://doi.org/10.1186/1742-4690-6-S3-P404

P14-15 LB. The safety and immunogenicity of HIV-1 vaccines based on DNA and replication competent vaccinia vector in phase I clinical trial

Cite

Register to see more suggestions